Oral Dosage Forms of Catalase Associated with Probiotics Using Carboxymethylcellulose and Carboxymethylstarch: A Potential Approach for Intestinal Inflammation

Inflammatory bowel diseases frequently associated with oxidative stress phenomena represent an important component of intestinal inflammation. An excess of hydrogen peroxide (H2O2) is mucosa damaging, and its removal becomes a therapeutic strategy. The oral administration of antioxidant enzymes such as catalase remains challenging because enzyme activity can be rapidly impaired under gastric conditions. Carboxymethylcellulose (CMC)- and carboxymethylstarch (CMS)-based tablets for oral delivery of catalase were investigated. Tablets containing 30% (w/w) catalase were exposed for 2 h to simulated gastric fluid (SGF) followed by 5 h in simulated intestinal fluid (SIF). Approximately 58% of the initial catalase activity was recovered from the CMC-based tablets, and about 44% from the CMS-based tablets. Despite this partial recovery, both formulations retained sufficient functional activity to achieve near-complete degradation of 5 mM H2O2 in vitro within 240 min for CMC and 300 min for CMS. The incorporation of cross-linked starch improved the mechanical strength of the CMC-based tablets and maintained the percentage of catalase recovery. The association of catalase and probiotics within the same formulation was also examined. The co-formulated catalase–probiotics maintained bacterial viability following 2 h of gastric exposure and 5 h in SIF. The presence of catalase did not compromise the bacterial viability. It appears that such a system could provide a basis for future strategies simultaneously targeting intestinal oxidative stress and microbiota imbalance.

Authors

Institutions

Publication Details

Journal
International Journal of Molecular Sciences
Published
2026-11-18
DOI
https://doi.org/10.3390/ijms272210358
Primary Topic
Advanced Drug Delivery Systems
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Oral Dosage Forms of Catalase Associated with Probiotics Using Carboxymethylcellulose and Carboxymethylstarch: A Potential Approach for Intestinal Inflammation

Mircea Alexandru Mateescu, Younès Chorfi, Patrick Gosselin, Armelle Tchoumi Nerée et al.
2 links
International Journal of Molecular Sciences
Advanced Drug Delivery Systems
article

Oral Dosage Forms of Catalase Associated with Probiotics Using Carboxymethylcellulose and Carboxymethylstarch: A Potential Approach for Intestinal Inflammation

Mircea Alexandru Mateescu, Younès Chorfi, Patrick Gosselin, Armelle Tchoumi Nerée, Al Hadji Malick Dieye
article en

Abstract

Inflammatory bowel diseases frequently associated with oxidative stress phenomena represent an important component of intestinal inflammation. An excess of hydrogen peroxide (H2O2) is mucosa damaging, and its removal becomes a therapeutic strategy. The oral administration of antioxidant enzymes such as catalase remains challenging because enzyme activity can be rapidly impaired under gastric conditions. Carboxymethylcellulose (CMC)- and carboxymethylstarch (CMS)-based tablets for oral delivery of catalase were investigated. Tablets containing 30% (w/w) catalase were exposed for 2 h to simulated gastric fluid (SGF) followed by 5 h in simulated intestinal fluid (SIF). Approximately 58% of the initial catalase activity was recovered from the CMC-based tablets, and about 44% from the CMS-based tablets. Despite this partial recovery, both formulations retained sufficient functional activity to achieve near-complete degradation of 5 mM H2O2 in vitro within 240 min for CMC and 300 min for CMS. The incorporation of cross-linked starch improved the mechanical strength of the CMC-based tablets and maintained the percentage of catalase recovery. The association of catalase and probiotics within the same formulation was also examined. The co-formulated catalase–probiotics maintained bacterial viability following 2 h of gastric exposure and 5 h in SIF. The presence of catalase did not compromise the bacterial viability. It appears that such a system could provide a basis for future strategies simultaneously targeting intestinal oxidative stress and microbiota imbalance.

International Journal of Molecular SciencesVol. 27(22)
Université du Québec à Montréal (CA), Armand Frappier Museum (CA), Université de Montréal (CA)
Mitacs, Natural Sciences and Engineering Research Council of Canada
Good health and well-being
Advanced Drug Delivery Systems
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon